Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1996 Jan;33(1):29–35. doi: 10.1136/jmg.33.1.29

Diagnostic, predictive, and prenatal testing for facioscapulohumeral muscular dystrophy: diagnostic approach for sporadic and familial cases.

E Bakker 1, M J Van der Wielen 1, E Voorhoeve 1, P F Ippel 1, G W Padberg 1, R R Frants 1, C Wijmenga 1
PMCID: PMC1051808  PMID: 8825045

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is one of the common inherited neuromuscular disorders. The major gene involved, FSHD1, has been localised to chromosome 4q35. This 4q35 locus, detected by pE13-11 (D4F104S1), shows a mutation frequency of about 10% of the incidence. New mutants are characterised by de novo deletions of tens to hundreds of kilobases of DNA. Although these deletion fragments are very useful as a molecular genetic tool, their use in diagnostic DNA testing is hampered by multiple factors, particularly in familial cases. In this report we describe a protocol that can be used for DNA testing in well defined familial cases or proven de novo cases, and in the differential diagnosis of muscular dystrophy patients clinically suspected of having FSHD. In addition, we describe a prenatal diagnosis performed for FSHD1.

Full text

PDF
29

Images in this article

31Image
on p.31
32Image
on p.32
33Image
on p.33
34Image
on p.34

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakker E., Bonten E. J., De Lange L. F., Veenema H., Majoor-Krakauer D., Hofker M. H., Van Ommen G. J., Pearson P. L. DNA probe analysis for carrier detection and prenatal diagnosis of Duchenne muscular dystrophy: a standard diagnostic procedure. J Med Genet. 1986 Dec;23(6):573–580. doi: 10.1136/jmg.23.6.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bakker E., Veenema H., Den Dunnen J. T., van Broeckhoven C., Grootscholten P. M., Bonten E. J., van Ommen G. J., Pearson P. L. Germinal mosaicism increases the recurrence risk for 'new' Duchenne muscular dystrophy mutations. J Med Genet. 1989 Sep;26(9):553–559. doi: 10.1136/jmg.26.9.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Church G. M., Gilbert W. Genomic sequencing. Proc Natl Acad Sci U S A. 1984 Apr;81(7):1991–1995. doi: 10.1073/pnas.81.7.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gilbert J. R., Stajich J. M., Wall S., Carter S. C., Qiu H., Vance J. M., Stewart C. S., Speer M. C., Pufky J., Yamaoka L. H. Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD). Am J Hum Genet. 1993 Aug;53(2):401–408. [PMC free article] [PubMed] [Google Scholar]
  5. Lunt P. W., Compston D. A., Harper P. S. Estimation of age dependent penetrance in facioscapulohumeral muscular dystrophy by minimising ascertainment bias. J Med Genet. 1989 Dec;26(12):755–760. doi: 10.1136/jmg.26.12.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988 Feb 11;16(3):1215–1215. doi: 10.1093/nar/16.3.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Milner E. C., Lotshaw C. L., Willems van Dijk K., Charmley P., Concannon P., Schroeder H. W., Jr Isolation and mapping of a polymorphic DNA sequence pH30 on chromosome 4[HGM provisional no. D4S139]. Nucleic Acids Res. 1989 May 25;17(10):4002–4002. doi: 10.1093/nar/17.10.4002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Neuweiler J., Ruvolo V., Baum H., Grzeschik K. H., Balazs I. Isolation and characterization of a hypervariable region [D4S163] on chromosome 4. Nucleic Acids Res. 1990 Feb 11;18(3):691–691. doi: 10.1093/nar/18.3.691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Passos-Bueno M. R., Wijmenga C., Takata R. E., Marie S. K., Vainzof M., Pavanello R. C., Hewitt J. E., Bakker E., Carvalho A., Akiyama J. No evidence of genetic heterogeneity in Brazilian facioscapulohumeral muscular dystrophy families (FSHD) with 4q markers. Hum Mol Genet. 1993 May;2(5):557–562. doi: 10.1093/hmg/2.5.557. [DOI] [PubMed] [Google Scholar]
  10. Sarfarazi M., Wijmenga C., Upadhyaya M., Weiffenbach B., Hyser C., Mathews K., Murray J., Gilbert J., Pericak-Vance M., Lunt P. Regional mapping of facioscapulohumeral muscular dystrophy gene on 4q35: combined analysis of an international consortium. Am J Hum Genet. 1992 Aug;51(2):396–403. [PMC free article] [PubMed] [Google Scholar]
  11. Upadhyaya M., Jardine P., Maynard J., Farnham J., Sarfarazi M., Wijmenga C., Hewitt J. E., Frants R., Harper P. S., Lunt P. W. Molecular analysis of British facioscapulohumeral dystrophy families for 4q DNA rearrangements. Hum Mol Genet. 1993 Jul;2(7):981–987. doi: 10.1093/hmg/2.7.981. [DOI] [PubMed] [Google Scholar]
  12. Wevers C. W., Brouwer O. F., Padberg G. W., Nijboer I. D. Job perspectives in facioscapulohumeral muscular dystrophy. Disabil Rehabil. 1993 Jan-Mar;15(1):24–28. doi: 10.3109/09638289309165865. [DOI] [PubMed] [Google Scholar]
  13. Wijmenga C., Brouwer O. F., Padberg G. W., Frants R. R. Transmission of de-novo mutation associated with facioscapulohumeral muscular dystrophy. Lancet. 1992 Oct 17;340(8825):985–986. doi: 10.1016/0140-6736(92)92885-j. [DOI] [PubMed] [Google Scholar]
  14. Wijmenga C., Frants R. R., Brouwer O. F., Moerer P., Weber J. L., Padberg G. W. Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet. 1990 Sep 15;336(8716):651–653. doi: 10.1016/0140-6736(90)92148-b. [DOI] [PubMed] [Google Scholar]
  15. Wijmenga C., Hewitt J. E., Sandkuijl L. A., Clark L. N., Wright T. J., Dauwerse H. G., Gruter A. M., Hofker M. H., Moerer P., Williamson R. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet. 1992 Sep;2(1):26–30. doi: 10.1038/ng0992-26. [DOI] [PubMed] [Google Scholar]
  16. Wijmenga C., Padberg G. W., Moerer P., Wiegant J., Liem L., Brouwer O. F., Milner E. C., Weber J. L., van Ommen G. B., Sandkuyl L. A. Mapping of facioscapulohumeral muscular dystrophy gene to chromosome 4q35-qter by multipoint linkage analysis and in situ hybridization. Genomics. 1991 Apr;9(4):570–575. doi: 10.1016/0888-7543(91)90348-i. [DOI] [PubMed] [Google Scholar]
  17. Wijmenga C., van Deutekom J. C., Hewitt J. E., Padberg G. W., van Ommen G. J., Hofker M. H., Frants R. R. Pulsed-field gel electrophoresis of the D4F104S1 locus reveals the size and the parental origin of the facioscapulohumeral muscular dystrophy (FSHD)-associated deletions. Genomics. 1994 Jan 1;19(1):21–26. doi: 10.1006/geno.1994.1006. [DOI] [PubMed] [Google Scholar]
  18. van Deutekom J. C., Wijmenga C., van Tienhoven E. A., Gruter A. M., Hewitt J. E., Padberg G. W., van Ommen G. J., Hofker M. H., Frants R. R. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet. 1993 Dec;2(12):2037–2042. doi: 10.1093/hmg/2.12.2037. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES